CoQ10 dosage and evidence

What is CoQ10?

How does CoQ10 work?

Your cells make CoQ10 on their own. It sits inside the mitochondria, the parts of the cell that make energy, and helps pass energy along. In one of its forms, ubiquinol, it also works as an antioxidant and helps recycle vitamin E. Statins block an enzyme your body uses to make cholesterol. The same pathway also makes CoQ10. That shared pathway is why people thought CoQ10 would fix statin muscle pain. The idea makes sense, and the studies still found nothing. A good theory is not a result.

What have studies in people found about CoQ10?

One strong study in a specific group of sick people, and a clear failure for the most common reason people take it. No study in healthy adults has measured real health results.

• Q-SYMBIO: 420 patients with moderate to severe heart failure, on their usual treatment. Major heart problems hit 15% on CoQ10 against 26% on a dummy pill, about half the risk. Deaths from any cause were 10% against 18%.
• Timing matters in that study. At 16 weeks there was no difference. The benefit only showed up at two years. A short study would have called it a failure.
• Statin muscle pain: 7 studies with 321 patients found no effect on the pain, and no help staying on the statin.
• A later study took 41 patients whose statin pain was confirmed by switching them on and off the statin. They took 600 mg a day of ubiquinol for 8 weeks. Their pain did not improve.
• In a 42 person migraine study, 47.6% on CoQ10 had half as many attacks, against 14.4% on a dummy pill. That is a migraine result, not a longevity one.
• Ubiquinol is sold as much better absorbed. No study has compared ubiquinol with regular CoQ10 (ubiquinone) on a real health result.

What this does not tell you: Q-SYMBIO only proves something for the people in it: 420 people with diagnosed moderate to severe heart failure, already on treatment, over two years. It does not show that CoQ10 helps a healthy person. It does not show it helps someone with mild heart failure. It is also one study of middling size, and other heart failure studies are less consistent than that one result. On statin pain, a pooled result of nothing can hide a few people who do respond, and the studies were small.

What do people who took CoQ10 report?

This is what real people say happened to them, good and bad. Nobody measured it. A report cannot tell a real effect from the lift people get just from expecting it to work, from a diet or training change made at the same time, or from what was really in the vial. We still put it near the top. It is the next best thing to a study in people: what happens when real people use it, including what goes wrong.

• The ubiquinol against ubiquinone argument is the centre of gravity of the discussion and has run for years without resolving. The position that gets stated most often by long-standing members is that the price difference between the two forms is larger than any difference in how much the body absorbs, and that taking more of the cheaper form is the rational response.
• People who respond better to one form than the other are common, and the explanations offered within the threads lean toward brand and manufacturing differences rather than the oxidised or reduced state, which is itself contested.
• Statin-associated muscle symptoms are the most common reason people describe trying it. Reports go both ways in the same threads: complete resolution of cramping on a few hundred milligrams of the cheaper form, and no change at all on either form.
• The clearest negative is the opposite of the effect most people are after. Fatigue on it, resolving after stopping, is reported by multiple people, and blood pressure dropping is offered by some as the reason.
• A recurring worry raised in the mitochondrial threads is whether taking it for a long time makes the body make less of its own. People describe lower energy and changes in their thinking after stopping. That is a hypothesis people in the threads argue about rather than something anyone demonstrates.
• No-effect reports are frequent and are stated flatly, including by people who ran it for long periods in both forms.

Sources: Supplements and Brain Health threads on LongeCity comparing ubiquinol, ubiquinone and idebenone, plus threads on CoQ10 and fatigue, found by site-restricted search, September 2026. Nothing above is attributed to any specific post and no post is reproduced.

The state of the research

The evidence, in charts

The studies we cite

• Study in people2014
  The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO, a randomized double-blind trial

  Coenzyme Q10 cut deaths and hospital admissions in people with serious heart failure. Four hundred and twenty patients took it three times a day, or a dummy, for two years. Nobody involved knew which. Major heart events struck 15 percent of the treated group against 26 percent on the dummy, and about half as many died. The first sixteen weeks showed nothing at all, so the benefit only appeared with time. This is one trial of moderate size and it has not been repeated at this scale.

  420 patients with moderate to severe chronic heart failure, 100 mg three times daily, two years. Major adverse cardiovascular events 15% against 26%, hazard ratio 0.50 (95% CI 0.32 to 0.80, p = 0.003). Cardiovascular mortality 9% against 16% (p = 0.026) and all-cause mortality 10% against 18% (p = 0.018). The short-term 16-week endpoints were null.

  PMID 25282031 JACC Heart Failure
• Study in people2015
  A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy

  Even in people whose statin muscle pain was confirmed by taking them on and off the statin, CoQ10 did not help. 41 of those patients then took 600 mg a day of ubiquinol with their statin, or a dummy, for 8 weeks. Pain scores rose on the statin either way. Strength and fitness did not change. Blood CoQ10 did rise, so the pills were absorbed. Absorption is not a result.

  Statin myalgia first confirmed in 120 patients by an 8-week simvastatin versus placebo crossover. 41 who hurt on simvastatin and not on placebo were then randomised to simvastatin plus ubiquinol 600 mg/day or placebo for 8 weeks. Pain severity and interference rose on simvastatin regardless of CoQ10 (p = 0.53 and 0.56). Muscle strength and VO2max did not change.

  PMID 25545331 Atherosclerosis
• Study in people2005
  Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial

  CoQ10 cut migraine attacks in a small trial that is not about ageing. 42 people took 100 mg three times a day, or a dummy. By the third month, 47.6 percent on CoQ10 had half as many attacks, against 14.4 percent on the dummy. That is a migraine result in 42 people.

  42 adults with migraine randomised to CoQ10 100 mg three times daily or placebo. In month 3, CoQ10 was superior for attack frequency, headache-days and days with nausea. 50% responder rate 47.6% against 14.4% (number needed to treat 3).

  PMID 15728298 Neurology
• Review of studies2020
  Effect of coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: a systematic review and meta-analysis

  CoQ10 did not help statin muscle pain. This review pooled 7 studies with 321 patients who had muscle pain on a statin. The pain did not improve. People were no more likely to stay on their statin. Only 2 of the 8 studies reviewed found a benefit on their own, and each study had between 37 and 76 people.

  7 randomised placebo-controlled trials, 321 patients with statin-associated myalgia. No benefit on muscle symptoms, weighted mean difference minus 0.42 (95% CI minus 1.47 to 0.62), and no improvement in the proportion who stayed on their statin (RR 0.99). Only 2 of 8 reviewed studies were individually positive. Trials ranged from 37 to 76 participants.

  PMID 32179207 Atherosclerosis